nodes	percent_of_prediction	percent_of_DWPC	metapath
Mifepristone—AR—duct of salivary gland—salivary gland cancer	0.376	0.635	CbGeAlD
Mifepristone—PGR—connective tissue—salivary gland cancer	0.0192	0.0325	CbGeAlD
Mifepristone—PGR—epithelium—salivary gland cancer	0.0182	0.0308	CbGeAlD
Mifepristone—ABCC1—parotid gland—salivary gland cancer	0.0165	0.0279	CbGeAlD
Mifepristone—NR3C1—neck—salivary gland cancer	0.0155	0.0261	CbGeAlD
Mifepristone—AR—connective tissue—salivary gland cancer	0.0153	0.0259	CbGeAlD
Mifepristone—AR—epithelium—salivary gland cancer	0.0145	0.0245	CbGeAlD
Mifepristone—PGR—lymphoid tissue—salivary gland cancer	0.014	0.0237	CbGeAlD
Mifepristone—NR3C1—parotid gland—salivary gland cancer	0.0126	0.0213	CbGeAlD
Mifepristone—NR3C1—saliva-secreting gland—salivary gland cancer	0.0121	0.0204	CbGeAlD
Mifepristone—AR—lymphoid tissue—salivary gland cancer	0.0112	0.0189	CbGeAlD
Mifepristone—NR3C1—connective tissue—salivary gland cancer	0.0111	0.0187	CbGeAlD
Mifepristone—NR3C1—epithelium—salivary gland cancer	0.0105	0.0178	CbGeAlD
Mifepristone—NR3C1—lymphoid tissue—salivary gland cancer	0.0081	0.0137	CbGeAlD
Mifepristone—PGR—lymph node—salivary gland cancer	0.00792	0.0134	CbGeAlD
Mifepristone—AR—lymph node—salivary gland cancer	0.00631	0.0107	CbGeAlD
Mifepristone—ABCC1—lymph node—salivary gland cancer	0.006	0.0101	CbGeAlD
Mifepristone—ABCB1—epithelium—salivary gland cancer	0.00563	0.00952	CbGeAlD
Mifepristone—NR3C1—lymph node—salivary gland cancer	0.00457	0.00773	CbGeAlD
Mifepristone—ABCB1—lymphoid tissue—salivary gland cancer	0.00434	0.00733	CbGeAlD
Mifepristone—AR—Regulation of nuclear SMAD2/3 signaling—FOXO3—salivary gland cancer	0.00276	0.00677	CbGpPWpGaD
Mifepristone—AR—FOXA1 transcription factor network—CREBBP—salivary gland cancer	0.00273	0.00669	CbGpPWpGaD
Mifepristone—AR—SIDS Susceptibility Pathways—MYB—salivary gland cancer	0.00269	0.0066	CbGpPWpGaD
Mifepristone—AR—Androgen receptor signaling pathway—BRCA1—salivary gland cancer	0.00266	0.00651	CbGpPWpGaD
Mifepristone—PGR—Signaling by ERBB4—FGFR4—salivary gland cancer	0.00264	0.00647	CbGpPWpGaD
Mifepristone—AR—Notch-mediated HES/HEY network—CREBBP—salivary gland cancer	0.00259	0.00635	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—ZIM2—salivary gland cancer	0.00248	0.00607	CbGpPWpGaD
Mifepristone—ABCB1—lymph node—salivary gland cancer	0.00245	0.00414	CbGeAlD
Mifepristone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—CREBBP—salivary gland cancer	0.00238	0.00583	CbGpPWpGaD
Mifepristone—AR—Regulation of Androgen receptor activity—CREBBP—salivary gland cancer	0.00235	0.00577	CbGpPWpGaD
Mifepristone—PGR—Generic Transcription Pathway—MAML3—salivary gland cancer	0.0023	0.00563	CbGpPWpGaD
Mifepristone—PGR—Signaling by ERBB4—FOXO3—salivary gland cancer	0.00219	0.00537	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—UHRF1—salivary gland cancer	0.00211	0.00516	CbGpPWpGaD
Mifepristone—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOXO3—salivary gland cancer	0.0021	0.00514	CbGpPWpGaD
Mifepristone—NR3C1—SIDS Susceptibility Pathways—MYB—salivary gland cancer	0.00204	0.00501	CbGpPWpGaD
Mifepristone—ABCC1—Transmembrane transport of small molecules—SLC24A3—salivary gland cancer	0.00203	0.00498	CbGpPWpGaD
Mifepristone—PGR—Validated nuclear estrogen receptor alpha network—CCND1—salivary gland cancer	0.00197	0.00482	CbGpPWpGaD
Mifepristone—CYP3A4—Constitutive Androstane Receptor Pathway—SMC1A—salivary gland cancer	0.00191	0.00468	CbGpPWpGaD
Mifepristone—AR—Gene Expression—ZIM2—salivary gland cancer	0.00189	0.00462	CbGpPWpGaD
Mifepristone—AR—FOXA1 transcription factor network—EP300—salivary gland cancer	0.00186	0.00456	CbGpPWpGaD
Mifepristone—AR—Nongenotropic Androgen signaling—PIK3CA—salivary gland cancer	0.00182	0.00446	CbGpPWpGaD
Mifepristone—PGR—Validated nuclear estrogen receptor alpha network—EP300—salivary gland cancer	0.00181	0.00443	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—TOP2A—salivary gland cancer	0.0018	0.00442	CbGpPWpGaD
Mifepristone—PGR—Signaling by ERBB4—MAP2K2—salivary gland cancer	0.00179	0.00439	CbGpPWpGaD
Mifepristone—NR3C1—Regulation of Androgen receptor activity—CREBBP—salivary gland cancer	0.00179	0.00437	CbGpPWpGaD
Mifepristone—AR—Notch-mediated HES/HEY network—EP300—salivary gland cancer	0.00177	0.00432	CbGpPWpGaD
Mifepristone—AR—Generic Transcription Pathway—MAML3—salivary gland cancer	0.00175	0.00429	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—BRCA1—salivary gland cancer	0.00174	0.00426	CbGpPWpGaD
Mifepristone—NR3C1—Circadian Clock—CREBBP—salivary gland cancer	0.00173	0.00425	CbGpPWpGaD
Mifepristone—AR—Nongenotropic Androgen signaling—HRAS—salivary gland cancer	0.00169	0.00413	CbGpPWpGaD
Mifepristone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—FOXO3—salivary gland cancer	0.00168	0.00413	CbGpPWpGaD
Mifepristone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDH1—salivary gland cancer	0.00168	0.00412	CbGpPWpGaD
Mifepristone—AR—Regulation of nuclear SMAD2/3 signaling—CREBBP—salivary gland cancer	0.00168	0.00411	CbGpPWpGaD
Mifepristone—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—salivary gland cancer	0.00162	0.00397	CbGpPWpGaD
Mifepristone—NR3C1—Endoderm Differentiation—NOTCH1—salivary gland cancer	0.00161	0.00395	CbGpPWpGaD
Mifepristone—AR—Gene Expression—UHRF1—salivary gland cancer	0.0016	0.00393	CbGpPWpGaD
Mifepristone—AR—Regulation of Androgen receptor activity—EP300—salivary gland cancer	0.0016	0.00393	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—NFIB—salivary gland cancer	0.0016	0.00391	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—ARID4B—salivary gland cancer	0.0016	0.00391	CbGpPWpGaD
Mifepristone—AR—Coregulation of Androgen receptor activity—CCND1—salivary gland cancer	0.00156	0.00381	CbGpPWpGaD
Mifepristone—AR—Androgen receptor signaling pathway—CREBBP—salivary gland cancer	0.00156	0.00381	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—BRCA1—salivary gland cancer	0.00144	0.00353	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—ZIM2—salivary gland cancer	0.00143	0.00351	CbGpPWpGaD
Mifepristone—NR3C1—Generic Transcription Pathway—MAML3—salivary gland cancer	0.00133	0.00325	CbGpPWpGaD
Mifepristone—PGR—Generic Transcription Pathway—MAML2—salivary gland cancer	0.00129	0.00315	CbGpPWpGaD
Mifepristone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CREBBP—salivary gland cancer	0.00127	0.00312	CbGpPWpGaD
Mifepristone—NR3C1—Glucocorticoid receptor regulatory network—CREBBP—salivary gland cancer	0.00126	0.00309	CbGpPWpGaD
Mifepristone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—salivary gland cancer	0.00125	0.00307	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—ERBB2IP—salivary gland cancer	0.00122	0.00299	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—UHRF1—salivary gland cancer	0.00122	0.00298	CbGpPWpGaD
Mifepristone—NR3C1—Regulation of Androgen receptor activity—EP300—salivary gland cancer	0.00122	0.00298	CbGpPWpGaD
Mifepristone—AR—Gene Expression—NFIB—salivary gland cancer	0.00122	0.00298	CbGpPWpGaD
Mifepristone—AR—Gene Expression—ARID4B—salivary gland cancer	0.00122	0.00298	CbGpPWpGaD
Mifepristone—NR3C1—Circadian Clock—EP300—salivary gland cancer	0.00118	0.00289	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—ATM—salivary gland cancer	0.00117	0.00287	CbGpPWpGaD
Mifepristone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—salivary gland cancer	0.00115	0.00283	CbGpPWpGaD
Mifepristone—AR—Androgen receptor signaling pathway—CCND1—salivary gland cancer	0.00115	0.00282	CbGpPWpGaD
Mifepristone—AR—Regulation of nuclear SMAD2/3 signaling—EP300—salivary gland cancer	0.00114	0.0028	CbGpPWpGaD
Mifepristone—AR—Androgen receptor signaling pathway—PTEN—salivary gland cancer	0.00111	0.00272	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—MAML3—salivary gland cancer	0.00111	0.00271	CbGpPWpGaD
Mifepristone—AR—Androgen receptor signaling pathway—EP300—salivary gland cancer	0.00106	0.00259	CbGpPWpGaD
Mifepristone—NR3C1—AP-1 transcription factor network—CCND1—salivary gland cancer	0.00106	0.00259	CbGpPWpGaD
Mifepristone—NR3C1—AP-1 transcription factor network—PTEN—salivary gland cancer	0.00102	0.0025	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—CDH1—salivary gland cancer	0.00101	0.00248	CbGpPWpGaD
Mifepristone—AR—SIDS Susceptibility Pathways—CREBBP—salivary gland cancer	0.000993	0.00243	CbGpPWpGaD
Mifepristone—AR—Generic Transcription Pathway—MAML2—salivary gland cancer	0.00098	0.0024	CbGpPWpGaD
Mifepristone—NR3C1—AP-1 transcription factor network—EP300—salivary gland cancer	0.000974	0.00239	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—ATM—salivary gland cancer	0.000971	0.00238	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—SLC24A3—salivary gland cancer	0.000968	0.00237	CbGpPWpGaD
Mifepristone—PGR—Signaling by ERBB4—PTEN—salivary gland cancer	0.00095	0.00233	CbGpPWpGaD
Mifepristone—ABCC1—Transmembrane transport of small molecules—AQP1—salivary gland cancer	0.000934	0.00229	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—NFIB—salivary gland cancer	0.000923	0.00226	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—ARID4B—salivary gland cancer	0.000923	0.00226	CbGpPWpGaD
Mifepristone—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—salivary gland cancer	0.000866	0.00212	CbGpPWpGaD
Mifepristone—NR3C1—Glucocorticoid receptor regulatory network—EP300—salivary gland cancer	0.000858	0.0021	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—CREBBP—salivary gland cancer	0.000844	0.00207	CbGpPWpGaD
Mifepristone—AR—Gene Expression—MAML3—salivary gland cancer	0.000843	0.00206	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—WNT5B—salivary gland cancer	0.000814	0.00199	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—ISYNA1—salivary gland cancer	0.00081	0.00198	CbGpPWpGaD
Mifepristone—ABCB1—HIF-1-alpha transcription factor network—CREBBP—salivary gland cancer	0.000805	0.00197	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—IL17RD—salivary gland cancer	0.000786	0.00193	CbGpPWpGaD
Mifepristone—ABCC1—Disease—WNT5B—salivary gland cancer	0.000759	0.00186	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—CCND1—salivary gland cancer	0.000754	0.00185	CbGpPWpGaD
Mifepristone—NR3C1—SIDS Susceptibility Pathways—CREBBP—salivary gland cancer	0.000753	0.00184	CbGpPWpGaD
Mifepristone—NR3C1—Generic Transcription Pathway—MAML2—salivary gland cancer	0.000743	0.00182	CbGpPWpGaD
Mifepristone—ABCC1—Transmembrane transport of small molecules—NUP62—salivary gland cancer	0.000741	0.00181	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—salivary gland cancer	0.000735	0.0018	CbGpPWpGaD
Mifepristone—ABCC1—Disease—IL17RD—salivary gland cancer	0.000733	0.0018	CbGpPWpGaD
Mifepristone—ABCC1—Disease—CPSF4—salivary gland cancer	0.000733	0.0018	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PYGB—salivary gland cancer	0.000733	0.0018	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—PTEN—salivary gland cancer	0.000728	0.00178	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—MAML3—salivary gland cancer	0.000719	0.00176	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—ISYNA1—salivary gland cancer	0.000707	0.00173	CbGpPWpGaD
Mifepristone—NR3C1—AP-1 transcription factor network—TP53—salivary gland cancer	0.000697	0.00171	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—EP300—salivary gland cancer	0.000694	0.0017	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—NUP62—salivary gland cancer	0.000683	0.00167	CbGpPWpGaD
Mifepristone—AR—SIDS Susceptibility Pathways—EP300—salivary gland cancer	0.000676	0.00166	CbGpPWpGaD
Mifepristone—ABCC1—Disease—MAML3—salivary gland cancer	0.00067	0.00164	CbGpPWpGaD
Mifepristone—PGR—Signaling by ERBB4—PIK3CA—salivary gland cancer	0.00067	0.00164	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—MARCKS—salivary gland cancer	0.00066	0.00162	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—MC3R—salivary gland cancer	0.000641	0.00157	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—MAML3—salivary gland cancer	0.000639	0.00157	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—CCND1—salivary gland cancer	0.000625	0.00153	CbGpPWpGaD
Mifepristone—PGR—Signaling by ERBB4—HRAS—salivary gland cancer	0.00062	0.00152	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—MAML2—salivary gland cancer	0.000619	0.00152	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—ST3GAL4—salivary gland cancer	0.000617	0.00151	CbGpPWpGaD
Mifepristone—NR3C1—Glucocorticoid receptor regulatory network—TP53—salivary gland cancer	0.000614	0.0015	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PYGB—salivary gland cancer	0.000614	0.0015	CbGpPWpGaD
Mifepristone—PGR—Generic Transcription Pathway—NOTCH1—salivary gland cancer	0.000607	0.00149	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—PTEN—salivary gland cancer	0.000603	0.00148	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA1—salivary gland cancer	0.000588	0.00144	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—MARCKS—salivary gland cancer	0.000576	0.00141	CbGpPWpGaD
Mifepristone—ABCC1—Disease—ST3GAL4—salivary gland cancer	0.000575	0.00141	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—EP300—salivary gland cancer	0.000575	0.00141	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—SMC1A—salivary gland cancer	0.000572	0.0014	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—DTX4—salivary gland cancer	0.00056	0.00137	CbGpPWpGaD
Mifepristone—PGR—Generic Transcription Pathway—CREBBP—salivary gland cancer	0.00055	0.00135	CbGpPWpGaD
Mifepristone—ABCB1—HIF-1-alpha transcription factor network—EP300—salivary gland cancer	0.000548	0.00134	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PYGB—salivary gland cancer	0.000535	0.00131	CbGpPWpGaD
Mifepristone—ABCC1—Disease—DTX4—salivary gland cancer	0.000522	0.00128	CbGpPWpGaD
Mifepristone—AR—Gene Expression—NUP62—salivary gland cancer	0.000521	0.00128	CbGpPWpGaD
Mifepristone—NR3C1—SIDS Susceptibility Pathways—EP300—salivary gland cancer	0.000513	0.00126	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—ISYNA1—salivary gland cancer	0.000511	0.00125	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PHGDH—salivary gland cancer	0.0005	0.00123	CbGpPWpGaD
Mifepristone—AR—Integrated Breast Cancer Pathway—TP53—salivary gland cancer	0.000497	0.00122	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—ST3GAL4—salivary gland cancer	0.000482	0.00118	CbGpPWpGaD
Mifepristone—AR—Gene Expression—MAML2—salivary gland cancer	0.000472	0.00116	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—FGF16—salivary gland cancer	0.000464	0.00114	CbGpPWpGaD
Mifepristone—AR—Generic Transcription Pathway—NOTCH1—salivary gland cancer	0.000463	0.00113	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—AQP1—salivary gland cancer	0.000444	0.00109	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—AQP1—salivary gland cancer	0.000437	0.00107	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PHGDH—salivary gland cancer	0.000436	0.00107	CbGpPWpGaD
Mifepristone—AR—Gene Expression—SMC1A—salivary gland cancer	0.000436	0.00107	CbGpPWpGaD
Mifepristone—ABCC1—Disease—FGF16—salivary gland cancer	0.000432	0.00106	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—PIK3CA—salivary gland cancer	0.000425	0.00104	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—ST3GAL4—salivary gland cancer	0.00042	0.00103	CbGpPWpGaD
Mifepristone—AR—Generic Transcription Pathway—CREBBP—salivary gland cancer	0.000419	0.00103	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—MARCKS—salivary gland cancer	0.000416	0.00102	CbGpPWpGaD
Mifepristone—ABCC1—Disease—NUP62—salivary gland cancer	0.000414	0.00101	CbGpPWpGaD
Mifepristone—AR—Integrated Pancreatic Cancer Pathway—TP53—salivary gland cancer	0.000411	0.00101	CbGpPWpGaD
Mifepristone—ABCC1—Disease—VCAN—salivary gland cancer	0.000411	0.00101	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—MAML2—salivary gland cancer	0.000403	0.000986	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—salivary gland cancer	0.000396	0.00097	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—NUP62—salivary gland cancer	0.000395	0.000968	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PYGB—salivary gland cancer	0.000387	0.000948	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—ISYNA1—salivary gland cancer	0.000385	0.000944	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—AQP1—salivary gland cancer	0.000382	0.000934	CbGpPWpGaD
Mifepristone—ABCC1—Disease—MAML2—salivary gland cancer	0.000375	0.000919	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—ISYNA1—salivary gland cancer	0.000363	0.000889	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—MAML2—salivary gland cancer	0.000358	0.000877	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—NUP62—salivary gland cancer	0.000352	0.000863	CbGpPWpGaD
Mifepristone—NR3C1—Generic Transcription Pathway—NOTCH1—salivary gland cancer	0.000351	0.00086	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—NUP62—salivary gland cancer	0.000347	0.00085	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—VCAN—salivary gland cancer	0.000344	0.000843	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—salivary gland cancer	0.000344	0.000843	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—JAG1—salivary gland cancer	0.000344	0.000842	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—FGFR4—salivary gland cancer	0.000342	0.000838	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—FBXW7—salivary gland cancer	0.000337	0.000825	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—SMC1A—salivary gland cancer	0.000331	0.00081	CbGpPWpGaD
Mifepristone—ABCC1—Disease—JAG1—salivary gland cancer	0.00032	0.000785	CbGpPWpGaD
Mifepristone—ABCC1—Disease—FGFR4—salivary gland cancer	0.000319	0.000781	CbGpPWpGaD
Mifepristone—NR3C1—Generic Transcription Pathway—CREBBP—salivary gland cancer	0.000318	0.000779	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PHGDH—salivary gland cancer	0.000316	0.000773	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—MARCKS—salivary gland cancer	0.000314	0.000769	CbGpPWpGaD
Mifepristone—ABCC1—Disease—FBXW7—salivary gland cancer	0.000314	0.000769	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—ST3GAL4—salivary gland cancer	0.000304	0.000744	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—NUP62—salivary gland cancer	0.000303	0.000741	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—CREBBP—salivary gland cancer	0.000302	0.00074	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—VCAN—salivary gland cancer	0.0003	0.000735	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—MARCKS—salivary gland cancer	0.000296	0.000725	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—NOTCH1—salivary gland cancer	0.000292	0.000716	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PYGB—salivary gland cancer	0.000292	0.000715	CbGpPWpGaD
Mifepristone—ABCC1—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.000287	0.000703	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—FOXO3—salivary gland cancer	0.000284	0.000696	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—AQP1—salivary gland cancer	0.000276	0.000675	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PYGB—salivary gland cancer	0.000275	0.000674	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—CREBBP—salivary gland cancer	0.000265	0.000649	CbGpPWpGaD
Mifepristone—ABCC1—Disease—FOXO3—salivary gland cancer	0.000265	0.000649	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—salivary gland cancer	0.000255	0.000624	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—salivary gland cancer	0.000246	0.000602	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PHGDH—salivary gland cancer	0.000238	0.000583	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ISYNA1—salivary gland cancer	0.000237	0.000582	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—salivary gland cancer	0.000234	0.000574	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—MAP2K2—salivary gland cancer	0.000232	0.000568	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—ST3GAL4—salivary gland cancer	0.000229	0.000561	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PHGDH—salivary gland cancer	0.000224	0.00055	CbGpPWpGaD
Mifepristone—AR—Gene Expression—NOTCH1—salivary gland cancer	0.000223	0.000545	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—NUP62—salivary gland cancer	0.000219	0.000536	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—VCAN—salivary gland cancer	0.000217	0.000531	CbGpPWpGaD
Mifepristone—ABCC1—Disease—MAP2K2—salivary gland cancer	0.000216	0.00053	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—ST3GAL4—salivary gland cancer	0.000216	0.000529	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—PTEN—salivary gland cancer	0.000216	0.000528	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—AQP1—salivary gland cancer	0.000208	0.00051	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—EP300—salivary gland cancer	0.000206	0.000504	CbGpPWpGaD
Mifepristone—AR—Gene Expression—CREBBP—salivary gland cancer	0.000202	0.000495	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—AQP1—salivary gland cancer	0.000196	0.00048	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—MARCKS—salivary gland cancer	0.000194	0.000474	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—NOTCH1—salivary gland cancer	0.00019	0.000465	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PYGB—salivary gland cancer	0.00018	0.000441	CbGpPWpGaD
Mifepristone—ABCC1—Disease—NOTCH1—salivary gland cancer	0.000177	0.000434	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—salivary gland cancer	0.000173	0.000425	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CREBBP—salivary gland cancer	0.000172	0.000422	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—NOTCH1—salivary gland cancer	0.000169	0.000414	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—salivary gland cancer	0.000168	0.000411	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—NUP62—salivary gland cancer	0.000165	0.000404	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—VCAN—salivary gland cancer	0.000164	0.000401	CbGpPWpGaD
Mifepristone—ABCC1—Disease—CREBBP—salivary gland cancer	0.000161	0.000393	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—NUP62—salivary gland cancer	0.000156	0.000381	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—VCAN—salivary gland cancer	0.000154	0.000378	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—CREBBP—salivary gland cancer	0.000153	0.000375	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—salivary gland cancer	0.000152	0.000373	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PHGDH—salivary gland cancer	0.000147	0.000359	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ST3GAL4—salivary gland cancer	0.000141	0.000346	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—CREBBP—salivary gland cancer	0.000137	0.000335	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—CREBBP—salivary gland cancer	0.000135	0.000329	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—AQP1—salivary gland cancer	0.000128	0.000314	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CCND1—salivary gland cancer	0.000127	0.000312	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—PTEN—salivary gland cancer	0.000123	0.000301	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—EP300—salivary gland cancer	0.000117	0.000287	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—CREBBP—salivary gland cancer	0.000117	0.000287	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PTEN—salivary gland cancer	0.000115	0.000281	CbGpPWpGaD
Mifepristone—ABCC1—Disease—EP300—salivary gland cancer	0.000109	0.000268	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—NUP62—salivary gland cancer	0.000102	0.000249	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—VCAN—salivary gland cancer	0.000101	0.000247	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PTEN—salivary gland cancer	9.61e-05	0.000235	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—EP300—salivary gland cancer	9.16e-05	0.000224	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—PIK3CA—salivary gland cancer	8.68e-05	0.000213	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—CREBBP—salivary gland cancer	8.48e-05	0.000208	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—TP53—salivary gland cancer	8.4e-05	0.000206	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PTEN—salivary gland cancer	8.38e-05	0.000205	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PIK3CA—salivary gland cancer	8.09e-05	0.000198	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—HRAS—salivary gland cancer	8.03e-05	0.000197	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—EP300—salivary gland cancer	7.99e-05	0.000196	CbGpPWpGaD
Mifepristone—ABCC1—Disease—HRAS—salivary gland cancer	7.49e-05	0.000183	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PIK3CA—salivary gland cancer	6.78e-05	0.000166	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CREBBP—salivary gland cancer	6.4e-05	0.000157	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PTEN—salivary gland cancer	6.06e-05	0.000148	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CREBBP—salivary gland cancer	6.03e-05	0.000148	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PIK3CA—salivary gland cancer	5.91e-05	0.000145	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—EP300—salivary gland cancer	5.78e-05	0.000141	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PTEN—salivary gland cancer	4.57e-05	0.000112	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—EP300—salivary gland cancer	4.36e-05	0.000107	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PTEN—salivary gland cancer	4.31e-05	0.000105	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PIK3CA—salivary gland cancer	4.27e-05	0.000105	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—EP300—salivary gland cancer	4.11e-05	0.000101	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CREBBP—salivary gland cancer	3.94e-05	9.66e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PIK3CA—salivary gland cancer	3.22e-05	7.9e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PIK3CA—salivary gland cancer	3.04e-05	7.44e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PTEN—salivary gland cancer	2.82e-05	6.9e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—EP300—salivary gland cancer	2.69e-05	6.58e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PIK3CA—salivary gland cancer	1.99e-05	4.86e-05	CbGpPWpGaD
